Molecular profiling in lung cancer

SummaryThe biology of non-small cell lung cancer (NSCLC) is driven by a  complex mutational landscape, and the detection of driver molecular alterations by next-generation sequencing is key for identification of druggable alterations. Thus, broad molecular profiling displays a standard-of-care approach particularly in patients with advanced adenocarcinoma at the time of the initial diagnosis, but also at the time of acquired resistance to tyrosine kinase inhibitors, guiding further treatment choices. Sequencing of plasma-circulating tumor DNA is of increasing importance in NSCLC diagnostics due to the easy accessibility, representing an optimal tool for longitud inal monitoring of the disease course.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research